# Grace Therapeutics, Inc.: Form 8-K, filed Sep 12, 2025

- Company: [Grace Therapeutics, Inc.](/companies/grce.md) (CIK 1444192)
- Form: 8-K
- Filed: 2025-09-12
- Accepted by EDGAR: Sep 12, 2025, 16:13 ET
- Period: 2025-09-12
- Accession: 0001140361-25-034845
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1444192/000114036125034845/ef20055483_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1444192/000114036125034845/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1444192/000114036125034845/ef20055483_8k.htm

Filed Sep 12, 2025.
Source: SEC EDGAR, the filing index for accession 0001140361-25-034845. Last ingested by Listed: Oct 26, 2026, 18:07 ET. No prices; not investment advice.